MED Medifast Inc

Price (delayed)

$180.76

Market cap

$2.08B

P/E Ratio

12.77

Dividend/share

$6.12

EPS

$14.15

Enterprise value

$1.99B

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a ...

Highlights
Medifast's gross profit has increased by 46% YoY and by 4.8% from the previous quarter
MED's revenue is up by 46% year-on-year and by 5% since the previous quarter
The company's quick ratio has shrunk by 54% YoY but it rose by 3.1% QoQ

Key stats

What are the main financial stats of MED
Market
Shares outstanding
11.51M
Market cap
$2.08B
Enterprise value
$1.99B
Valuations
Price to earnings (P/E)
12.77
Price to book (P/B)
9.66
Price to sales (P/S)
1.3
EV/EBIT
9.12
EV/EBITDA
8.58
EV/Sales
1.24
Earnings
Revenue
$1.6B
EBIT
$218.61M
EBITDA
$232.54M
Free cash flow
$40.27M
Per share
EPS
$14.15
Free cash flow per share
$3.48
Book value per share
$18.72
Revenue per share
$138.71
TBVPS
$36.47
Balance sheet
Total assets
$421.44M
Total liabilities
$205.41M
Debt
$31.04M
Equity
$216.02M
Working capital
$143.23M
Liquidity
Debt to equity
0.14
Current ratio
1.79
Quick ratio
0.67
Net debt/EBITDA
-0.37
Margins
EBITDA margin
14.5%
Gross margin
73.7%
Net margin
10.3%
Operating margin
13.6%
Efficiency
Return on assets
42.4%
Return on equity
81.4%
Return on invested capital
205.9%
Return on capital employed
90.9%
Return on sales
13.6%
Dividend
Dividend yield
3.39%
DPS
$6.12
Payout ratio
43.3%

MED stock price

How has the Medifast stock price performed over time
Intraday
-1.89%
1 week
0.14%
1 month
-4.6%
1 year
-37.29%
YTD
-13.69%
QTD
0.14%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$1.6B
Gross profit
$1.18B
Operating income
$218.53M
Net income
$164.75M
Gross margin
73.7%
Net margin
10.3%
Medifast's gross profit has increased by 46% YoY and by 4.8% from the previous quarter
MED's revenue is up by 46% year-on-year and by 5% since the previous quarter
The operating income rose by 34% YoY
MED's net income is up by 31% YoY

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
12.77
P/B
9.66
P/S
1.3
EV/EBIT
9.12
EV/EBITDA
8.58
EV/Sales
1.24
The price to earnings (P/E) is 46% less than the 5-year quarterly average of 24.1 and 18% less than the last 4 quarters average of 15.9
The EPS has increased by 33% year-on-year
The equity has grown by 24% YoY and by 7% from the previous quarter
MED's P/B is 23% below its 5-year quarterly average of 12.7 and 21% below its last 4 quarters average of 12.4
The P/S is 49% lower than the 5-year quarterly average of 2.6 and 26% lower than the last 4 quarters average of 1.8
MED's revenue is up by 46% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Medifast business performance
The return on invested capital has dropped by 97% year-on-year and by 39% since the previous quarter
The return on sales has declined by 9% year-on-year and by 4.2% since the previous quarter
The ROA has decreased by 7% YoY and by 6% from the previous quarter
MED's ROE is down by 4.7% QoQ and by 4.5% YoY

Dividends

What is MED's dividend history
DPS
$6.12
Dividend yield
3.39%
Payout ratio
43.3%
Recent dividends

Financial health

How did Medifast financials performed over time
The total assets is 105% greater than the total liabilities
The company's quick ratio has shrunk by 54% YoY but it rose by 3.1% QoQ
Medifast's total liabilities has increased by 36% YoY and by 4.9% QoQ
Medifast's debt is 86% less than its equity
Medifast's debt to equity has soared by 133% YoY but it has decreased by 13% from the previous quarter
The equity has grown by 24% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.